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Summary 
Macrophage colony-stimulating  factor (M-C3F) is known to play an important role in osteoclast 
formation. However, its actions on mature cells have not been fully characterized. We now report 
that M-CSF dramatically stimulates osteoclastic motility and spreading; osteoclasts  responded 
to a gradient of M-CSF with orientation, and random cell polarization occurred after isotropic 
exposure. M-CSF also supported the survival of osteoclasts by preventing apoptosis. Paradoxically, 
M-CSF inhibits bone resorption by isolated osteoclasts.  We found that this was effected pre- 
dominantly by reduction in the number of excavations. Thus, M-CSF showed a propensity to 
suppress resorption through a reduction in the proportion of cells that were resorbing bone. 
Our data suggest that apart from the established role of M-CSF in the provision of precursors 
for osteoclastic induction, a major role for M-CSF in bone resorption is to enhance osteoclastic 
survival, migration, and chemotaxis. It seems appropriate that during these processes resorptive 
functions should be suppressed. We suggest that M-CSF continues to modulate osteoclastic activity 
once osteoclasts  are on resorptive sites, through regulation of the balance between resorption 
and migration, such that not only the quantity, but the spatial pattern of resorption can be 
controlled by adjacent  M-CSF-secreting cells of osteoblastic lineage. 
I 
t has been established  that the osteoclast is derived from 
hemopoietic  precursors, from a lineage shared with mono- 
nuclear phagocytes, from which lineage it is induced to di- 
verge by a contact-dependent interaction with bone marrow 
stromal cells (1-3). This divergence is marked by the acquisi- 
tion  of characteristics  not  seen  in  other progeny of the 
monouudear phagocytic lineage,  such as the ability to re- 
sorb bone, calcitonin receptors, and high levels of vitronectin 
receptor expression; and by the absence from osteoclasts  of 
several enzymatic and antigenic characteristics of macrophages 
(4-7). 
The  deficiency  of macrophages and  ostcoclasts  in  os- 
teopetrotic (op/op) mice has been shown to be due to the 
absence of macrophage colony-stimulating factor (M=CSF)  x, 
caused by a mutation early in the coding region of the M=CSF 
gene (8, 9). The ddideucy of both cell types can be made 
good, both in vivo and in hemopoietic cultures in vitro, by 
administration of M-CSF (10-13). For macrophages this de- 
~Abbreviatlo~ used in  ti~ pat~:  CTR,  calcitoffm receptor;  M-CSF, 
macrophage  colony-stimulating  factor;  TEM,  transmission  electron 
microscopy; TRAP, tartrate-resistant acid phosphatase_ 
Pendency on M-CSF is consistent with the well-described 
ability of M-CSF to promote the survival, proliferation, and 
functional capacity of macrophages (14-19). In contrast, the 
effects of M-CSF on mature osteoclasts,  which are known 
to have M-CSF receptors (20) are less well characterized,  and 
appeared, moreover, in the single reported study of M-CSF 
effects on mature osteoclasts,  to show not enhanced func- 
tion, as might be expected from the role of M-CSF in os- 
teodast formation, but inhibition of bone resorption (21). 
In view of these apparently paradoxical  actions of M-CSF 
on osteoclast  formation and function, we elected to more 
fully characterize the actions of M-CSF on mature osteoclasts. 
Materlals and Methods 
Recombinant human M-CSF was kindly provided by Dr. S. C. 
Clark, (Genetics  Institute, Cambridge, MA). Mithramycin, cyclo- 
hexamide,  and bovine serum albumin (BSA; used at I mg/ml) were 
purchased from Sigma Chemical Co. (Poole, UK). Medium 199 
(Imperial Laboratories, Andover, UK) was used for osteoclast iso- 
lation and sedimentation, and Eagle's minimum  essential medium 
(MEM; Imperial  Laboratories)  was used for subsequent  incubations 
unless stated otherwise. Media  were supplemented  with 100 IU/ml 
benzylpenidllin and 100/~g/ml streptomycin (both from Imperial 
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CO2 in humidified air. 
Slices of devitalized bovine cortical bone, used as substrates for 
osteoclastic resorption, were prepared as previously described (22). 
Bone slices (4  x  3  x  0.1  mm) were cut with a low-speed saw 
(Isomet Corp., Springfield,  VA), cleaned by ultrasonication in sterile 
water, washed, immersed in alcohol, and stored dry at room tem- 
perature. 
Isolation and Culture of Osteoclasts.  Osteoclasts were disaggregated 
from neonatal rat or mouse long bones as previously described (23). 
Wistar rats or MF-1 mice from the St. George's Hospital Medical 
School colony were killed by cervical dislocation within 3 d of  birth. 
The femora, tibiae, and humeri were removed, freed of adherent 
soft tissues, and cut across their epiphyses. The bones were curetted 
with a scalpel bhde into 2 m1199 and the fragments were vigorously 
agitated using a plastic Pasteur pipette. Larger fragments were al- 
lowed to sediment for 30 s and the resulting suspensions were used 
in the experiments described in the next section. All experiments 
were designed in such a way that all variables received osteoclasts 
from the same suspension. All experiments were performed using 
rat osteoclasts unless  otherwise specified. 
Survival Studies.  Bone cell suspensions were added either to three 
wells of a 100  x  18 mm multiwdl Petri dish (Sterilin,  Teddington, 
UK) containing bone slices, or to wells of a 96-well plate (Sterilin) 
containing Thermanox (Gibco, Uxbridge, UK) coverslips and in- 
cubated for 15 rain. Bone slices and coverslips were then removed, 
washed in PBS, and placed into individual wells of a 96-well plate. 
Cells were incubated for 2 or 24 h in a total vol of 200 #1MEM/BSA 
in the presence of M-CSF or vehicle. Calcitonin receptor (CTR)- 
positive ceUs were identified using iodinated salmon CT (24). For 
this, coverslips  were washed in 199 and transferred to fresh wells 
containing 200 #1 199/BSA with labeled CT (0.2 nM). After 60 
rain incubation at room temperature, coverslips were fixed in for- 
malin, washed extensively, air dried, and then coated with K5 nu- 
clear emulsion (Ilford Inc., Basildon, UK). They were developed 
after 7 d at 4~  and counterstained with Meyer's hematoxylin. 
Osteoclasts on bone slices were fixed for 2 rain in formalin and 
stained for tartrate-resistant acid phosphatase (TRAP) (25).  The 
substrate used was naphthol AS-B1 phosphate. Tartrate resistance 
was assessed in the presence of 0.05 M sodium tartrate. CTR-positive 
and TRAP-positive multinuclear cells were counted by light mi- 
croscopy. In some experiments, osteoclastic survival was assessed 
by marking the position of a number of osteoclasts using a grid. 
Their video images were then recorded,  and the survival of the 
same osteoclasts was assessed 1-24 h after the addition of M-CSF 
(5 ng/ml)  or vehicle  to the cultures. 
Morphologic changes associated  with apoptosis were assessed 
by acridine orange staining (Sigma Chemical Co.) (5 #g/m1) of 
coverslips fixed after incubation, and by transmission electron mi- 
croscopy. Transmission electron microscopy (TEM) was performed 
on cells incubated for 6 or 24 h in the presence or absence of M-CSF 
(5 ng/ml). Cells adherent to 100-mm diameter petri dishes  after 
incubation were washed with PBS and then fixed with 2 ml 5% 
glutaraldehyde in 0.2 M cacodylate buffer. They were then removed 
from the dish with a call scraper (Costar, High Wycombe, UK), 
pelleted by centrifugation,  and processed for TEM. 
Phenotypic Assessment.  The potential of both rat and mouse os- 
teoclasts to develop macrophagic markers normally not seen on os- 
teoclasts was assessed after 2 or 24 h incubation on Thermanox 
coverslips in the presence of M-CSF (5 ng/ml). Immunocytochem- 
istry was performed on these cultures with: CD45, a monoclonal 
antibody (mAb) to rat leukocyte common antigen; ED2, a mAb 
to rat macrophages; M1/70.15.1,  a mAb to mouse macrophages; 
MoMa-2 (Serotec Ltd., Oxford, UK), a mAb to mouse monocytes 
and macrophages; and F4/80, a mAb to mouse macrophages (Dr. 
S. Gordon, Sir William Dunn School of Pathology, Oxford, UK) 
using standard immunoalkaline phosphatase staining techniques. 
All the above mAbs bind to monocytes and/or macrophages but 
not osteoclasts ([see reference 7; 26, 27]; and unpublished observa- 
tions).  Nonspecific  esterase  activity was  determined  by  the  c~ 
naphthyl acetate method. 
Assessment of Bone Resorption.  The number of osteoclastic ex- 
cavations and the plan area of bone resorbed were quantified by 
SEM after 6 and 24 h incubation as previously described (22). Bone 
slices were removed from wells, immersed in 10% NaOCI for 10 
min to remove cells, washed in distilled water, dried, and sputter- 
coated with gold. The entire surface of each bone slice was then 
examined in a scanning electron microscope ($90;  Cambridge In- 
struments, Cambridge, UK). The depth of excavations was deter- 
mined on the same specimens using a confocal microscope (I.asertec 
Corporation,  London,  UK). 
Time-lapse Observations.  The bone cell suspension, obtained as 
above, was added to 25 cm  z tissue culture flasks (Sterilin)  and in- 
cubated for 15 rain to allow osteoclast sedimentation and attach- 
ment. Nonadherent  and loosely adherent cells were removed by 
washing with PBS. 10 ml of MEM/BSA were placed into the flasks 
and the cells were incubated for 30 man. Flasks were then sealed 
and placed in the incubation chamber of an Olympus 1MT-373 
inverted microscope (Gallenkamp and Co., Ltd., London,  UK). 
A suitable osteoclast-containing field was chosen and recorded for 
30 rain on a time-lapse video recorder at 1/60 normal speed.  Ve- 
hicle or M-CSF was then added in 0.5 ml prewarmed MEM/BSA 
and recording continued. 
Measurement of Osteoclast Spread Area.  Osteoclasts  were in- 
cubated on bone slices or Thermanox coverslips  as above in the 
presence of M-CSF or vehicle for 2 h. They were then fixed and 
stained for TRAP activity. Osteodast spread area was determined 
with a light microscope linked to a computer-assisted image ana- 
lyzer (Perceptive  Instruments,  Cambridge, UK). 
Osteoclast Appearance in the Scanning Electron Microscope.  Os- 
teoclasts were sedimented onto bone slices as previously described 
and incubated for 30 min. They were then incubated in the pres- 
ence of M-CSF (5 ng/ml) or vehicle for 5-60 min. Bone slices were 
fixed in 5% glutaraldehyde in 0.2 M cacodylate buffer for 30 min, 
dehydrated through graded alcohols,  and critical-point dried from 
COz. Specimens were sputter-coated with gold and examined in 
a Zeiss DSM 940 scanning electron microscope (Zeiss, Oberkochen, 
Germany). 
Assessment of Osteoclast Polarization.  Orientation was evaluated 
in a Zigmond orientation chamber as described by Zigmond (28). 
Osteoclasts were sedimented onto the central area of a 22  x  40 
mm glass coverslip for 15 rain. The coverslip was then washed and 
Figure  1.  Phase  contrast photomicrographs showing morphological changes preceding and associated  with apoptosis in osteoclasts. In this osteoclast, 
successive loci of pseudopodial activity in different parts of the cell periphery are followed by the development of a complex shape (a-d). The onset 
of apoptosis was first detected in the upper right pole of the osteoclast (e), rapidly followed by the rest of the call (f), which shows reduced spreading, 
an increase in phase granularity, rounding,  and cytoplasmic blebbing (g and k). Bar, 20 ~m. (a), time 0; (b), 60 min; (c), 120 rain; (d),  180 min; 
(e), 186 min;  (f), 190 min; (g), 195 min; (k), 198 min. 
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The cell-free area of the coverslip was wiped and the coverslip was 
inverted over the bridge. The chamber was placed into a 37~  in- 
cubator, and 100/zl 199/BSA was added to one well and 100/~1 
199/BSA containing 0.1-10 ng/ml M-CSF was added to the other. 
After incubation for 30 min the osteoclasts present over the bridge 
were assessed for orientation with an inverted microscope using 
a  x25 objective. Osteoclasts were adjudged to show orientation 
when pseudopodia were evident on one side of the cell and retrac- 
tion filopodia and lobolxxtia  were visible on the opposite side. When 
orientated, osteoclasts that showed pseudopodia in the 180  ~ sector 
towards the test well were scored positive, whereas the pseudopodia 
that were in the 180 ~ sector towards the control well were scored 
negative (28). The same criteria were used for assessment of polari- 
zation of osteoclasts after incubation on coverslips in a uniform 
solution of M-CSF (0.05-50 ng/ml) for 30 min. 
Statistical Methods.  Differences between groups were analyzed 
with the Student's t test. 
Results 
In the absence of exogenous  growth factor, isolated os- 
teodasts showed morphological changes suggestive of apop- 
tosis that were prevented by M-CSF (Figs. 1-3). Within 24 h, 
most osteoclasts showed an abrupt  change of behavior, in 
Figure 2.  Fluorescence photomicrographs of osteoclasts stained with acridine orange after incubation with M-CSF (5 ng/ml) (a and c) or vehicle 
(b and d) for 6 or 24 h. (a) 6 h: rehtively diffuse nuclear staining, with visible nudeoli;  (b) a cell incubated without M-CSF for 6 h shows irregular 
nuclear staining; (c) osteoclast incubated for 24 h in M-CSF shows intact nuclear structure; (d) control cell after a 24 h incubation shows nuclear fragmen- 
tation.  Bar, 10/~m. 
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granular, and formed blebs (Fig. 1). Osteoclasts detached on 
gentle agitation of the culture vessel in this state,  or if left 
undisturbed, showed nuclear and cytoplasmic disintegration 
after  a period of hours. Cells  stained with acridine orange 
after fixation showed that changes in nuclear texture, with 
chromatin dumping, preceded the terminal rounding and bleb- 
bing phase identified in phase contrast observations, with nu- 
clear changes becoming visible within 2 h of isolation (Fig. 
2). Electron microscopical observations also revealed nuclear 
changes characteristic of apoptosis (Fig. 3). Osteodastic apop- 
tosis was neither prevented nor induced by cycloheximide (1 
/~M) or mithramycin (100 riM), suggesting  that in osteoclasts, 
activation of a latent enzyme (29)  may be involved in the 
process  (data not shown). 
Osteodastic survival was considerably enhanced by addi- 
tion of M-CSF to cultures, whether survival was measured 
as TRAP- or CTR-positive multinudear cells (Fig. 4). En- 
hanced survival was also documented by observation of par- 
ticular osteoclasts by time-lapse video microscopy for 24 h. 
We found that 2 out of 20 control cells, and 13 out of 20 
osteoclasts incubated with M-CSF (5 ng/ml) survived. Apop- 
tosis in serum-flee medium appeared to be initiated and be- 
come irreversible relatively soon after osteoclast isolation, since 
M-CSF addition 2 h after isolation did not significantly in- 
crease survival compared to M-CSF-ffee cultures (Fig. 4). This 
action of M-CSF to sustain osteoclastic survival was reflected 
in suppression of apoptosis-associated changes in nuclear mor- 
phology (Figs.  2 and 3). 
Because we have previously found (21) that M-CSF inhibits 
bone resorption, the improved survival of osteoclasts in M-CSF 
was unexpected. We therefore tested, in view of the close 
lineage relationship between macrophages and osteoclasts, for 
evidence of a possible action for M-CSF in diverting osteodasts 
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Figure  4.  Number of CTR-positive cells or TRAP-positive cells per 
cm2 after incubation  for 2 or 24 h in the presence of M-CSF or vehicle. 
M-CSF was added at the initiation of incubation except where shown (at 
2 h) to be added 2 h after the start  of incubation,  xp <0.05; '~p <0.01 
vs.  24-h control cultures.  Each column is derived from five cultures, 
Figure  3.  Transmission  electron micrograph of osteoclast  incubated  with M-CSF (5 ng/ml) (a)  or vehicle (b) for 24 h.  (a) Dispersed  chromatin 
in two morphologically normal nuclei in M-CSF-treated cell; (b) condensed  chromatin in nuclei of apoptotic osteoclast incubated  without M-CSF. 
Bar,  10/~m. 
1737  Fuller  et al. towards an alternative, macrophagic role.  We found, how- 
ever, that rat osteodasts incubated in M-CSF (5 ng/ml) for 
24 h remained nonspecific esterase-negative,  despite suppres- 
sion of  bone resorption by M-CSF during this time; and both 
rat and murine (which similarly were suppressed from apop- 
tosis by M-CSF [data not shown]) osteoclasts remained nega- 
tive for all the antigenic markers used, which are present on 
macrophages but not detected on osteodasts (7,  26,  27). 
Moreover,  osteoclasts  incubated for 24 h with M-CSF (Fig. 
4) remained strongly CTR-positive, not subjectively different 
in grain density from osteoclasts  incubated for 2 h. 
Since macrophages are unable to excavate bone (30), a fur- 
ther clue to a possible action of M-CSF to induce osteoclasts 
to undertake macrophagic differentiation might be reflected 
in a progressive  decline in the ability of the cells to resorb 
bone. Thus, the ability of M-CSF to inhibit resorption would 
become greater with increasing incubation time. We found 
that the reverse was the case. Resorption-suppression was two 
orders of magnitude greater for resorption measured after 6 h 
of incubation (Fig.  5), than after 18 h (21), and resorption- 
suppression at 6 h showed a very similar sensitivity to M-CSF 
to the dose-responsiveness  of osteoclasts  for increased  sur- 
vival by M-CSF (Fig. 4).  Moreover, if resorption was com- 
pared after 6 and 24 h in the same experiment (Table 1), it 
appears  that while the resorption rate falls in control cul- 
tures, perhaps attributable to the decrease in osteodast number 
during culture, the resorption rate was sustained in M-CSF- 
incubated cultures at a relatively steady rate through the in- 
cubation period. Thus, we found no evidence of a progres- 
sive increase with time in resorption-suppression by M-CSF, 
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which might have reflected differentiation of osteoclasts  to- 
wards a nonresorptive cell type. 
Similar to our results on plastic, osteoclast survival on bone 
was enhanced by the presence  of M-CSF (Fig.  4 and Table 
1). This is unlike our experience in similar experiments which 
were performed in the presence  of serum (21), which im- 
proves the survival of osteoclasts  in vitro (data not shown). 
The lack of significant inhibition of bone resorption mea- 
sured after 24 h in the present experiment is attributable to 
the impaired survival of osteoclasts in the absence of M-CSF 
and serum (Table 1). 
Table  1.  Bone  Resorption  by  Osteoclasts  Incubated for  6  or 24  h  in  M-CSF  or  Vehicle 
Kate of resorption 
Multinucleate  per bone slice 
No. of excavations  Plan  area of  Plan area resorbed  cells  per bone  for periods 0-6 
per bone slice  excavations  Excavation  depth  per bone slice  slice  and 6-24 h 
mean  +_  SEM  #m 2  +_  SEAl  Ixm  +_  SEM  Ixm  ~  +  SEM  mean  +_  SEM  #mZ/h  +_  SEM 
Control  6 h  5 _+  0.6  813  _+  41  4.4  _+  0.2  4084  _+  536  6.3  _+ 0.7  681  _+  89 
(42)  (211)  (63) 
24 h  5.9  +  0.7  1300  _+  74*  4.5  _+  0.3  7703  +_  1116"  5.7  _+  1.0  201  _+  69* 
(42)  (248)  (41) 
M-CSF  6 h  2.2  _+  0.3*  749  _+  61  3.6  -+ 0.2*  1675  _+  275*  9.9  _+  1.1 s  279  _+  46* 
(41)  (92)  (43) 
24 h  5.5  _+  0.9"  1172  _+  64*  3.9  +  0.2  6062  _+  1004"  10.2  _+  1.5  s  244  _+  58 
(42)  (229)  (27) 
Osteoclasts were incubated on bone slices for 6 or 24 h in M-CSF (50 ng/ml) or vehicle, before quantification of cell number and bone resorption. 
Numbers in parentheses represent the number of observations. Each group is derived from seven experiments, with six bone slices per variable per 
experiment. A  random sample  of excavations was  assessed for excavation depth. 
S p  <0.05 vs.  control;  "p <0.01  vs.  6  h; * p  <0.01 vs. control. 
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cludes the possibility (which would resolve the discordant 
actions of M-CSF to stimulate survival and suppress resorp- 
tion), that the previously identified decrease in plan area of 
resorption (21) might have been associated with an increase 
in resorption depth. 
In control cultures most osteoclasts  produced an excava- 
tion (see Table 1). Since the number of excavations did not 
increase between 6 and 24 h, there appeared to be little initi- 
ation of fresh excavations after 6 h of incubation in control 
cultures (Table 1), consistent with the poor viability of these 
cells. However, osteoclasts  incubated with M-CSF seemed 
to continue to initiate resorption after 6 h since the number 
of excavations was more than doubled at 24 h compared to 
6 h. Excavation size (plan area and depth of each excavation) 
was only slightly reduced by M-CSF, while the proportion 
of osteoclasts resorbing bone appeared to have been reduced 
at 6 h from ~80% in control cultures to '~20% in M-CSF. 
Thus, the predominant explanation for the suppression of 
bone resorption by M-CSF appeared to be through a reduc- 
tion in the proportion of osteoclasts that were resorbing bone, 
rather than through an equal suppression of the activity of 
each osteoclast. 
The dear suppression of  bone resorption by M-CSF seemed 
perverse for a cytokine that supported osteoclastic  survival, 
and raised the possibility that M-CSF might stimulate some 
function in osteoclasts other than bone resorption. We found 
that addition of M-CSF to osteoclasts in serum-free medium 
was consistently followed within 30 s by a dramatic change 
in behavior (Fig.  6), consisting of a rapid increase in pseu- 
dopodial motility, with the formation of a peripheral phase- 
dense band that soon encircled the cell, associated with waves 
of pseudopodial activity starting at the cell periphery and 
passing towards the centre of the cell. This was accompanied 
by cell spreading. Motility then returned towards control levels, 
and cytoplasmic spreading was maintained, for at least the 
Figure  6.  Morphological changes induced in an osteoclast by exposure to M-CSF. Phase-contrast micrographs show appearance of osteoclast immedi- 
ately before M-CSF (5 ng/ml) addition (a), and 1 (b), 2 (c), 5 (d),  10 (e), and 30 0  c) min afterwards.  A peripheral phase-dark margin develops rapidly, 
associated with intense local cytoplasmic motility and followed by cell spreading.  Pseudopodial  motility then abates but the cell maintains a relatively 
well-spread  state Or). Bar,  10/zm. 
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duration of the experiments  (24 h), at a higher level. The 
cell spreading phenomenon showed a dose-response relation- 
ship, and occurred on both plastic and bone substrates (Figs. 
7 and 8). After incubation in M-CSF, osteodasts  showed an 
appearance similar to that seen in serum, and the morpho- 
logical change induced by M-CSF was not consistent in the 
presence of serum (data not shown). No change in behavior 
was observed after addition of vehicle. The rapid, dramatic, 
transient change in behavior resembled a response to chemo- 
tactic agents (31). Such agents also characteristically induce 
orientation in gradients,  and polarization  in isotropic  con- 
centrations of the same agents (32, 33). We found that os- 
teodasts oriented towards an M-CSF source (Figs. 9 and 10), 
and an increased proportion of osteoclasts became polarized 
after 30 rain of incubation in 0.05 and 0.5 ng/ml of M-CSF 
(percent  _+  SEM:vehide  28  _+  18; M-CSF 0.05  ng/ml:66 
_+  17 [P <0.01  vs. control]; 0.5 ng/ml:46  _+  11 IF <0.05] 
[six cultures per variable]). At concentrations of 5 ng/ml and 
above osteoclasts regularly showed active pseudopods  over 
at least most, and generally the whole of their circumfer- 
ence, a phenomenon also observed after incubation  of other 
target cells in high uniform concentrations  of chemotactic 
agents (32, 33). 
Discussion 
The actions of  M-CSF on cells of  the mononuclear  phago- 
cyte system have been well characterized,  and include pro- 
motion of survival, proliferation, differentiation, and several 
aspects of mature cell function (14-18). Although it has re- 
cently been shown that M-CSF is also important in osteoclast 
formation (8, 9), much less is known about the mechanisms 
by which M-CSF acts in osteoclast differentiation,  or about 
its role, ff any, in the regulation of the function of  mature cells. 
We now report that M-CSF promotes the survival of ma- 
ture osteoclasts through suppression of apoptosis.  Survival 
was enhanced at very low concentrations of  M-CSF, suggesting 
that the phenomenon might have physiological significance. 
However, although this is the first identification  of an os- 
teoclastic survival factor, others may exist. Kodama et al. (34) 
have shown prolonged survival of osteoclasts in op/op mice, 
which are deficient in M-CSF, after  a single injection  of 
M-CSF. 
The ability of  M-CSF to support osteoclast survival makes 
it even more surprising  that it inhibits  bone resorption in 
vitro. Nevertheless, we found that the responsiveness of os- 
Figure  8.  Scanning electron  micrographs  of osteoclasts incubated  with vehicle (a) or M-CSF (5 ng/ml) (b) for 5 min. In vehicle, osteodasts  show 
an irregular  outline of filopodia,  with a microviUous dorsal  surface. This is transformed  by M-CSF into a more smoothly lobulated  contour,  with 
loss of microvilli and  the development  of dorsal ruses.  Bar  ~- 10 #m. 
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teoclasts to resorption-inhibition was very similar to their 
sensitivity to M-CSF as a survival factor.  It seems perverse 
that increased survival be associated with a reduction in the 
primary function of a cell.  One possibility, in view of the 
shared origin of osteoclasts and macrophages, is that M-CSF 
might  enhance macrophagic differentiation in  osteoclasts. 
Thus, it is known that in the presence of  bone marrow stromal 
cells, hemopoietic precursors differentiate into osteodasts, but 
in the presence of M-CSF alone, the same precursors differen- 
tiate only into macrophages (1, 3). Just as mononuclear phago- 
cytes may dedifferentiate on removal of M-CSF (35), and have 
been found by some (36)  (but not all  [27])  workers to be 
capable of differentiation into osteoclasts in the presence of 
stromal osteoclast-forming activity (SOFA), it may be that, 
upon removal from SOFA, osteodasts become capable of mac- 
rophagic differentiation in the presence of M-CSF. 
Our results do not support this possibility. We found no 
evidence for macrophagic differentiation of osteoclasts in the 
presence of M-CSF.  Moreover, if resorption inhibition by 
M-CSF were explicable as differentiation towards macrophages, 
which cannot  excavate  bone  (30),  we would  anticipate  a 
progressive decline in the rate of resorption by osteoclasts 
incubated in M-CSF. We found that bone resorption was in- 
hibited to a similar degree early and late in the incubation 
period. 
A  second possible  explanation for the inverse  actions of 
M-CSF on osteoclastic survival and resorptive function might 
be that the stimulation of osteodasts, implied by its potent 
action on survival, may be of some aspect of osteoclastic func- 
tion that is not directly involved in the process of  bone resorp- 
tion itself. 
Our results suggest that M-CSF plays a role in osteoclastic 
Figure 10.  Phase contrast photomicrograph of osteoclast  viewed on central bridge of a perspex Zigmond chamber after incubation with M-CSF 
(1 ng/ml) in the test chamber (on right ofphotoraicragraph) that shows  orientation towards source of gradient. Bar,  25 #m. 
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30 s of application, caused a dramatic increase in pseudopodial 
motility in isolated osteoclasts,  associated with increased cy- 
toplasmic spreading. The dramatic and transient behavioral 
change is typical of the response of cells to a rapid change 
in the concentration of a chemotactic agent (31-33, 37). Also 
typical of a chemotactic response, osteodasts showed posi- 
tive orientation to M-CSF gradients, and an increase in the 
proportion of cells demonstrating random polarization in 
isotropic  concentrations of M-CSF.  Polarization  of pseu- 
dopodial activity implies migration in the direction of the 
expanded, leading pseudopods in many cell types, including 
osteoclasts (38,  39;  see Fig.  1, a-c). 
Bone resorption occurs throughout development and adult 
life in intricate and dynamic patterns. There is much evidence 
that this spatial organization of osteoclastic activity is under 
the control of cells of the osteoblastic lineage (4,  40,  41), 
which have been shown to produce M-CSF (42).  Our data 
suggest that the function of this M-CSF production may be 
to attract osteoclasts to resorptive sites, and to maintain their 
survival during migration. 
A role for M-CSF to induce osteodastic migration through 
tissues  may be analogous to its role in the M-CSF-depen- 
dent migration through tissues  of trophoblastic cells (43), 
monocytes (44, 45), and some c-f  ms-expressing breast cancer 
cells (46). There is evidence that suggests that osteoclasts might 
share other migratory mechanisms with mononuclear phago- 
cytes: recently, osteoclasts have been shown to possess receptors 
for urokinase-type plasminogen activator (47),  and to pro- 
duce messenger RNA for collagenase (48).  These neutral- 
pH active proteinases appear not to play a direct role in the 
excavation of  bone (49), but they are requ/red for bone resorp- 
tion in intact bone tissue (50), perhaps to enable osteoclastic 
migration to resorptive sites. 
Although M-CSF can stimulate some functions in macro- 
phages as in osteoclasts, it is interesting that M-CSF sup- 
presses activities that are directly related to the ultimate func- 
tion of both cell types; bone resorption in osteoclasts,  and 
superoxide generation in macrophages (51). Both activities 
may be inappropriate during migration,  and this suggests 
that a primary role of M-CSF might be to induce migration 
of target cells through tissues. 
It is intriguing to note that the dominant action of M-CSF 
on bone resorption by osteoclasts was not to suppress  the 
rate of resorption by all osteoclasts equally, but to reduce the 
proportion of osteodasts that were resorbing bone. This sug- 
gests that bone resorption and migration might represent al- 
ternative states of osteoclastic activity, that are to some ex- 
tent  mutually exclusive.  Consistent  with  this,  resorptive 
surfaces in vivo show a scalloped appearance, suggestive of 
episodic resorption and migration (52-54).  We have previ- 
ously found that contact with bone mineral induces resorp- 
tive behavior in osteoclasts; and because the mineral phase 
of bone is resorbed more rapidly than the organic phase, resorp- 
tion itself progressively reduces mineral contact (55).  Thus, 
on bone surfaces in vivo, as on our bone slices in vitro, mineral 
contact and M-CSF exposure might represent opposing stimuli 
that determine the behavioral state of osteodasts, such that 
as resorption proceeds, migration becomes increasingly likely. 
Consistent with this thesis is the relative shallowness of ex- 
cavations in normal animals in vivo, compared with the more 
irregular resorptive surface in SEM photographs of bone sur- 
faces from op/op animals lacking M-CSF (56). 
Our data thus suggest that the role of M-CSF in bone 
resorption is to enhance osteoclastic survival, migration, and 
chemotaxis. It seems appropriate that during these processes 
resorptive functions should be suppressed. We suggest that 
M-CSF continues to modulate osteoclastic activity once os- 
teodasts are on resorptive sites through regulation of the bal- 
ance between resorption and migration, such that not only 
the quantity but the spatial pattern of resorption can be con- 
trolled by  adjacent  M-CSF-secreting  cells  of osteoblastic 
lineage. 
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